DK1208113T3 - 17beta-acyl-17alfa-propynyl-11beta-(cycloamino)arylsterioder og afledte heraf med hormonantagonistiske egenskaber - Google Patents

17beta-acyl-17alfa-propynyl-11beta-(cycloamino)arylsterioder og afledte heraf med hormonantagonistiske egenskaber

Info

Publication number
DK1208113T3
DK1208113T3 DK00959867T DK00959867T DK1208113T3 DK 1208113 T3 DK1208113 T3 DK 1208113T3 DK 00959867 T DK00959867 T DK 00959867T DK 00959867 T DK00959867 T DK 00959867T DK 1208113 T3 DK1208113 T3 DK 1208113T3
Authority
DK
Denmark
Prior art keywords
17alpha
17beta
acyl
propynyl
steriodes
Prior art date
Application number
DK00959867T
Other languages
English (en)
Inventor
C Edgar Cook
John A Kepler
Jill M O'reilly
Original Assignee
Res Triangle Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Triangle Inst filed Critical Res Triangle Inst
Application granted granted Critical
Publication of DK1208113T3 publication Critical patent/DK1208113T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00959867T 1999-09-03 2000-09-05 17beta-acyl-17alfa-propynyl-11beta-(cycloamino)arylsterioder og afledte heraf med hormonantagonistiske egenskaber DK1208113T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/389,212 US6740645B1 (en) 1999-09-03 1999-09-03 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
PCT/US2000/024274 WO2001018025A2 (en) 1999-09-03 2000-09-05 17alpha propynyl 11-aryl steroids

Publications (1)

Publication Number Publication Date
DK1208113T3 true DK1208113T3 (da) 2009-08-31

Family

ID=23537322

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00959867T DK1208113T3 (da) 1999-09-03 2000-09-05 17beta-acyl-17alfa-propynyl-11beta-(cycloamino)arylsterioder og afledte heraf med hormonantagonistiske egenskaber

Country Status (14)

Country Link
US (1) US6740645B1 (da)
EP (1) EP1208113B1 (da)
JP (1) JP4837858B2 (da)
KR (1) KR100733932B1 (da)
AT (1) ATE431832T1 (da)
AU (1) AU780077B2 (da)
CA (1) CA2384184C (da)
CY (1) CY1109451T1 (da)
DE (1) DE60042238D1 (da)
DK (1) DK1208113T3 (da)
ES (1) ES2326787T3 (da)
NO (1) NO322108B1 (da)
PT (1) PT1208113E (da)
WO (1) WO2001018025A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041145A1 (en) 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
DK1265911T3 (da) * 2000-03-17 2008-09-29 Us Gov Health & Human Serv 17-alfa-substitueret-11-beta-substitueret-4-aryl og 21-substitueret 19-norpregnadiendion som antiprogestationelle midler
CA2516319C (en) * 2003-02-28 2012-09-18 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
EP3865502A1 (en) * 2010-03-22 2021-08-18 Allergan Pharmaceuticals International Limited Compositions and methods for non-toxic delivery of cdb-2914
CN103130862B (zh) * 2011-11-30 2016-04-13 成都伊诺达博医药科技有限公司 醋酸乌利司他关键中间体3,20-双(亚乙二氧基)-19-去甲孕甾-5,9-二烯-17-醇的合成方法
SG11201407397WA (en) 2012-05-31 2014-12-30 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona
WO2016090139A1 (en) * 2014-12-03 2016-06-09 Evestra, Inc. Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer
CN115521352B (zh) * 2022-11-01 2024-05-14 湖南新合新生物医药有限公司 一种甲基双烯醇酮的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
WO1997041145A1 (en) * 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
IL122740A (en) 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties

Also Published As

Publication number Publication date
JP2003508540A (ja) 2003-03-04
ES2326787T3 (es) 2009-10-20
NO20021037D0 (no) 2002-03-01
KR20020092906A (ko) 2002-12-12
CY1109451T1 (el) 2014-08-13
EP1208113B1 (en) 2009-05-20
WO2001018025A3 (en) 2001-09-20
EP1208113A4 (en) 2003-01-02
CA2384184A1 (en) 2001-03-15
WO2001018025A2 (en) 2001-03-15
DE60042238D1 (de) 2009-07-02
NO20021037L (no) 2002-04-05
NO322108B1 (no) 2006-08-14
KR100733932B1 (ko) 2007-07-03
JP4837858B2 (ja) 2011-12-14
PT1208113E (pt) 2009-08-25
AU780077B2 (en) 2005-02-24
US6740645B1 (en) 2004-05-25
CA2384184C (en) 2008-07-08
AU7111300A (en) 2001-04-10
ATE431832T1 (de) 2009-06-15
EP1208113A2 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
CY1109451T1 (el) 17βητα-ακυλ-17αλφα-προπυνυλ-11βητα-(κυκλικα αμινο)αρυλ στεροειδη και παραγωγα αυτων που εχουν ιδιοτητες ορμονικου ανταγωνιστη
MXPA00008738A (es) 20-ceto-1 1b-arilesteroides y sus derivados teniendo propiedades agonistas o antagonistas hormonales.
DE60135919D1 (de) Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate
PT1193270E (pt) Pirrolobenzodiazepinas
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
CY1111317T1 (el) Παραγωγα 4-φαινυλοπυριδινης και χρηση αυτων ως ανταγωνιστων υποδοχεων της νκ-1
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE60121461D1 (de) Kondensierte pyridoindolderivate
DE69932432T8 (de) 17-beta-amino-und hydroxylamino-11-beta-arylsteroide und deren derivate mit hormonalen agonist- oder antagonisteigenschaften
DK1135403T3 (da) 17beta-acyl-17alfa-propynyl-11beta-arylsteroider og deres derivater med agonistiske eller antagonistiske hormonale egenskaber
PL352638A1 (en) Novel derivatives and analogues of galanthamin
CY1106444T1 (el) 17b-νιτρο-11β-αρυλοστepοειδη και παραγωγα αυτων ως ορμονικοι αγωνιστες ή ανταγωνιστες
ATE375359T1 (de) Aminosterolderivate und ihre verwendungen
NO20014588D0 (no) Immunmodulatoriske steroider, spesielt hemihydrat av 16<alfa>- bromepiandrosteron
PT1196428E (pt) Esteroides substituidos com 11 beta-aril-17, 17-espirotiolano
DE60015567D1 (de) Herbizide zusammensetzungen und anwendungsverfahren
DE60220699D1 (de) Tibolonformulierungen
SE9901273D0 (sv) Novel compounds
SE9900438D0 (sv) The pharmacological use of certian cystine derivatives
GB9912227D0 (en) Quick-setting medical plaster of paris
FIU990032U0 (fi) Hirsikerautapari